Variables | Overall survival | Disease-free survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Sex | ||||||
Female | 1 | – | ||||
Male | 2.010 | 0.994–4.065 | 0.052 | – | ||
Surgical approach | ||||||
Open surgery | 1 | 1 | ||||
MIE | 0.606 | 0.384–0.958 | 0.032 | 0.848 | 0.449–1.600 | 0.610 |
Location | ||||||
Upper third | – | 1 | ||||
Middle third | – | 2.179 | 1.026–4.628 | 0.043 | ||
Lower third | – | 0.835 | 0.272–2.564 | 0.752 | ||
ypTNM stage | ||||||
I | 1 | 1 | ||||
II | 1.267 | 0.617–2.600 | 0.519 | 1.245 | 0.515–3.013 | 0.626 |
III | 2.080 | 1.254–3.451 | 0.005 | 0.918 | 0.444–1.899 | 0.817 |
IV | 3.969 | 1.500–10.505 | 0.006 | 1.051 | 0.236–4.680 | 0.948 |
Postoperative therapy | ||||||
No | 1 | 1 | ||||
Yes | 0.668 | 0.415–1.074 | 0.096 | 0.115 | 0.057–0.231 | < 0.001 |